Introduction and transmission of SARS-CoV-2 lineage B.1.1.7, Alpha variant, in Denmark

Author:

Michaelsen Thomas Y.,Bennedbæk Marc,Christiansen Lasse E.,Jørgensen Mia S. F.,Møller Camilla H.,Sørensen Emil A.,Knutsson Simon,Brandt Jakob,Jensen Thomas B. N.,Chiche-Lapierre Clarisse,Collados Emilio F.,Sørensen Trine,Petersen Celine,Le-Quy Vang,Sereika Mantas,Hansen Frederik T.,Rasmussen Morten,Fonager Jannik,Karst Søren M.,Marvig Rasmus L.,Stegger Marc,Sieber Raphael N.,Skov Robert,Legarth Rebecca,Krause Tyra G.,Fomsgaard Anders,Andersen Kasper S.,Andersen Martin H.,Berg Amalie,Bielidt Susanne R.,Dall Sebastian M.,Dvarionaite Erika,Hansen Susan H.,Jørgensen Vibeke R.,Kirkegaard Rasmus H.,Saei Wagma,Nicolajsen Trine B.,Østergaard Stine K.,Brøndum Rasmus F.,Bøgsted Martin,Hose Katja,Sagi Tomer,Pakanec Miroslaw,Fuglsang-Damgaard David,Mølvadgaard Mette,Krarup Henrik,Svarrer Christina W.,Christiansen Mette T.,Ingham Anna C.,Johannesen Thor B.,Basterrechea Martín,Lilje Berit,Ellegaard Kirsten,Matusevicius Povilas,Christoffersen Lars B.,Tang Man-Hung E.,Ng Kim L.,Edslev Sofie M.,Baig Sharmin,Larsen Ole H.,Skipper Kristian A.,Vang Søren,Handberg Kurt J.,Nielsen Marc T. K.,Kobel Carl M.,Andersen Camilla,Tarpgaard Irene H.,Ellermann-Eriksen Svend,Castruita José A. S.,Schneider Uffe V.,Jacobsen Nana G.,Andersen Christian Ø.,Pedersen Martin S.,Schønning Kristian,Kirkby Nikolai,Nielsen Lene,Nilsson Line L.,Friis Martin B.,Sundelin Thomas,Hansen Thomas A.,Skov Marianne N.,Sydenham Thomas V.,Nielsen Xiaohui C.,Schouw Christian H.,Jensen Anders,Marmolin Ea S.,Coia John E.,Andersen Dorte T.,Albertsen MadsORCID,

Abstract

Abstract Background In early 2021, the SARS-CoV-2 lineage B.1.1.7 (Alpha variant) became dominant across large parts of the world. In Denmark, comprehensive and real-time test, contact-tracing, and sequencing efforts were applied to sustain epidemic control. Here, we use these data to investigate the transmissibility, introduction, and onward transmission of B.1.1.7 in Denmark. Methods We analyzed a comprehensive set of 60,178 SARS-CoV-2 genomes generated from high-throughput sequencing by the Danish COVID-19 Genome Consortium, representing 34% of all positive cases in the period 14 November 2020 to 7 February 2021. We calculated the transmissibility of B.1.1.7 relative to other lineages using Poisson regression. Including all 1976 high-quality B.1.1.7 genomes collected in the study period, we constructed a time-scaled phylogeny, which was coupled with detailed travel history and register data to outline the introduction and onward transmission of B.1.1.7 in Denmark. Results In a period with unchanged restrictions, we estimated an increased B.1.1.7 transmissibility of 58% (95% CI: [56%, 60%]) relative to other lineages. Epidemiological and phylogenetic analyses revealed that 37% of B.1.1.7 cases were related to the initial introduction in November 2020. The relative number of cases directly linked to introductions varied between 10 and 50% throughout the study period. Conclusions Our findings corroborate early estimates of increased transmissibility of B.1.1.7. Both substantial early expansion when B.1.1.7 was still unmonitored and continuous foreign introductions contributed considerably to case numbers. Finally, our study highlights the benefit of balanced travel restrictions and self-isolation procedures coupled with comprehensive surveillance efforts, to sustain epidemic control in the face of emerging variants.

Funder

Poul Due Jensen Foundation

Villum Fonden

Styrelsen for forskning og uddannelse

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine

Reference57 articles.

1. R. Andrew, L. Nick, P. Oliver, B. Wendy, B. Jeff, C. Alesandro, C. Tom, P. Tom, L. R. David, V. Erik, Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations, virological.org. 2020 Available at https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563.

2. Shu Y, McCauley J. GISAID: Global initiative on sharing all influenza data – from vision to reality. Euro Surveill. 2017;22. https://doi.org/10.2807/1560-7917.es.2017.22.13.30494.

3. New and Emerging Respiratory Virus Threats Advisory Group, “NERVTAG meeting on SARS-CoV-2 variant under investigation VUI-202012/01” (2020).

4. European Centre for Disease Prevention and Control. Risk related to the spread of new SARS-CoV-2 variants of concern in the EU/EEA – first update. Stockholm: ECDC; 2021.

5. Statens Serum Institut, SARS-CoV-2-virusvarianter. SSI’s portal med information om COVID-19. 2021, Available at https://covid19.ssi.dk/virusvarianter.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3